Researchers at Karolinska Institutet, in Sweden have identified a molecule, known as CID 661578, that helps stimulate the growth of new insulin-producing cells, and uncovered how it works, opening up new potential diabetes treatments.
The molecule binds to a protein called MNK2, leading to greater beta-cell regeneration, higher insulin production, and lower blood glucose levels.

FOOTAGE: MolView / Definigen / Envato Elements
PHOTOS: Ulf Sirborn, Johannes Frandsén / Karolinska Institutet
COVER ART: MolView / Envato Elements
BACKGROUND: Tomislav Jakupec / Pixabay
MUSIC: Coma-media / Pixabay

STUDY:
“MNK2 deficiency potentiates β-cell regeneration via translational regulation”.
Christos Karampelias, Olov Andersson et al
Nature Chemical Biology
https://www.nature.com/articles/s4158...

STORY:
Karolinska Institutet
https://news.ki.se/study-describes-ne...
New Atlas
https://newatlas.com/medical/diabetes...